Research Article
PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma
Table 3
Univariate and multivariate Cox regression analyses for PFS in 87 NDMM patients.
| Variables | Univariate model | Multivariate model | | HR | 95% CI | | HR | 95% CI | |
| | 1.316 | 0.726-2.384 | 0.366 | | | | Male sex | 1.051 | 0.138-7.987 | 0.962 | | | | | 1.934 | 1.291-6.798 | 0.023 | 1.679 | 0.647-3.965 | 0.171 | | 1.102 | 0.569-2.133 | 0.774 | | | | | 1.645 | 1.525-4.087 | 0.067 | | 1.194 | 0.586-2.432 | 0.625 | | | | | 1.070 | 0.545-2.101 | 0.845 | | | | | 0.773 | 0.421-1.423 | 0.409 | | | | | 1.757 | 0.973-3.171 | 0.062 | | | | PLP2 ++ & +++ | 1.865 | 1.031-3.375 | 0.039 | 1.549 | 0.988-2.386 | 0.095 |
|
|